PRESS RELEASE published on 09/17/2025 at 22:15, 1 year 1 month ago NANOBIOTIX Announces New Results From a Phase 1 Study Evaluating JNJ-1900 (NBTXR3) in Combination With Immune Checkpoint Inhibitors as a 2L+ Therapy for Patients With Primary Cutaneous Melanoma Resistant to Anti-PD-1 Nanobiotix announces new results from a Phase 1 study evaluating JNJ-1900 (NBTXR3) in combination with immune checkpoint inhibitors as a 2L+ therapy for patients with primary cutaneous melanoma resistant to anti-PD-1. Favorable safety profile and early efficacy signals observed Melanoma NANOBIOTIX Immune Checkpoint Inhibitors Phase 1 Study JNJ-1900
BRIEF published on 09/12/2025 at 19:05, 1 year 1 month ago Nanobiotix Announces Voting Rights and Share Capital Details Voting Rights Shares Euronext Nasdaq NANOBIOTIX
PRESS RELEASE published on 09/12/2025 at 19:00, 1 year 1 month ago Voting Rights and Shares Capital of the Company Nanobiotix releases voting rights and shares capital details. The company is listed on Euronext Paris and Nasdaq, pioneering biotechnology for treatment advancements Euronext Paris Voting Rights Nasdaq Shares Capital NANOBIOTIX
BRIEF published on 09/02/2025 at 22:20, 1 year 1 month ago Nanobiotix at the HC Wainwright Global Investment Conference Investors Biotechnology Conference Therapeutics NANOBIOTIX
PRESS RELEASE published on 09/02/2025 at 22:15, 1 year 1 month ago Nanobiotix to Participate in the H.C. Wainwright 27th Annual Global Investment Conference Nanobiotix to participate in H.C. Wainwright 27th Annual Global Investment Conference with a fireside chat featuring company management. Nanoparticle-based treatments for cancer and major diseases Fireside Chat NANOBIOTIX H.C. Wainwright Conference Late-stage Biotechnology Nanoparticle-based Treatments
BRIEF published on 08/27/2025 at 08:05, 1 year 2 months ago Nanobiotix Announces Voting Rights and Shares Capital Update Euronext Paris Voting Rights Biotechnology Shares Capital NANOBIOTIX
PRESS RELEASE published on 08/27/2025 at 08:00, 1 year 2 months ago Voting Rights and Shares Capital of the Company Nanobiotix announces voting rights and shares capital details as per French Commercial Code regulations. The late-stage clinical biotech company focuses on disruptive therapies in oncology, bioavailability, and CNS disorders Voting Rights French Commercial Code Biotechnology Shares Capital NANOBIOTIX
BRIEF published on 08/11/2025 at 11:34, 1 year 2 months ago Threshold Crossings by The Goldman Sachs Group, Inc. at Nanobiotix Actions Financial Market Goldman Sachs Crossing Thresholds NANOBIOTIX
BRIEF published on 07/07/2025 at 22:20, 1 year 3 months ago NANOBIOTIX: Reclassification and New Patent for JNJ-1900 (NBTXR3) Patent NANOBIOTIX Regulatory JNJ-1900 Harmonization
PRESS RELEASE published on 07/07/2025 at 22:15, 1 year 3 months ago NANOBIOTIX Announces Regulatory Harmonization and New Composition of Matter Patent Filed for JNJ-1900 (NBTXR3) Nanobiotix announces regulatory harmonization and new composition of matter patent filed for JNJ-1900 (NBTXR3), aiming to reinforce global positioning of potential first-in-class radioenhancer NANOBIOTIX JNJ-1900 Global Positioning Regulatory Harmonization Composition Of Matter Patent
Published on 10/30/2026 at 23:35, 1 day 13 hours ago Prospect Ridge Announces Closing of Critical Metals Flow-through Unit Private Placement
Published on 10/30/2026 at 23:30, 1 day 14 hours ago Revolve Enters into Definitive Agreement to Acquire Three Project, 6 MW Battery Storage Portfolio in Ontario
Published on 10/30/2026 at 19:00, 1 day 18 hours ago Electric Royalties Ltd. Announces Application for Warrant Extension
Published on 10/30/2026 at 15:30, 1 day 22 hours ago Bluejay Diagnostics Announces 1-for-4 Reverse Stock Split
Published on 11/01/2026 at 10:35, 2 hours 56 minutes ago Shenzhen Unveils APEC China 2026 Host-City Theme Song and Music Video
Published on 11/01/2026 at 05:00, 8 hours 31 minutes ago 2026 Yangtze River Culture Festival Opens in Yonglian Village, Zhangjiagang, Jiangsu
Published on 10/31/2026 at 16:35, 20 hours 56 minutes ago SKYWORTH Solar Announces Global Launch of Solavita as a Smart Microgrid Brand
Published on 10/30/2026 at 22:49, 1 day 14 hours ago EQS-Adhoc: STRATEC SELLS LOSS-MAKING BUSINESS, RECOGNIZES IMPAIRMENTS, AND AMENDS GUIDANCE
Published on 10/30/2026 at 23:00, 1 day 14 hours ago BIOPHYTIS REPORTS FIRST- HALF 2026 RESULTS AND PROVIDES AN UPDATE ON ITS STRATEGY
Published on 10/30/2026 at 12:00, 2 days 1 hour ago Capital increase through exercise of subscription rights